Animal models of migraine: looking at the component parts of a complex disorder

被引:103
作者
Bergerot, A.
Holland, P. R.
Akerman, S.
Bartsch, T.
Ahn, A. H.
MaassenVanDenBrink, A.
Reuter, U.
Tassorelli, C.
Schoenen, J.
Mitsikostas, D. D.
van den Maagdenberg, A. M. J. M.
Goadsby, P. J.
机构
[1] UCL Natl Hosp Neurol & Neurosurg, Headache Grp, Inst Neurol, London WC1N 3BG, England
[2] Univ Kiel, Dept Neurol, Kiel, Germany
[3] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA
[5] Erasmus MC, Dept Pharmacol, Rotterdam, Netherlands
[6] Charite Univ Med Berlin, Dept Neurol, D-10117 Berlin, Germany
[7] Univ Pavia, Univ Ctr Adapt Disorders & Headache, IRCCS, Neurol Inst C Mondino Fdn, I-27100 Pavia, Italy
[8] Univ Leige, Liege, Belgium
[9] Athens Naval Hosp, Dept Neurol, Athens, Greece
[10] Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands
[11] Leiden Univ, Med Ctr, Dept Neurol, NL-2300 RC Leiden, Netherlands
关键词
animal models of migraine; trigeminovascular-mediated nociception;
D O I
10.1111/j.1460-9568.2006.05036.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Animal models of human disease have been extremely helpful both in advancing the understanding of brain disorders and in developing new therapeutic approaches. Models for studying headache mechanisms, particularly those directed at migraine, have been developed and exploited efficiently in the last decade, leading to better understanding of the potential mechanisms of the disorder and of the action for antimigraine treatments. Model systems employed have focused on the pain-producing cranial structures, the large vessels and dura mater, in order to provide reproducible physiological measures that could be subject to pharmacological exploration. A wide range of methods using both in vivo and in vitro approaches are now employed; these range from manipulation of the mouse genome in order to produce animals with human disease-producing mutations, through sensitive immunohistochemical methods to vascular, neurovascular and electrophysiological studies. No one model system in experimental animals can explain all the features of migraine; however, the systems available have begun to offer ways to dissect migraine's component parts to allow a better understanding of the problem and the development of new treatment strategies.
引用
收藏
页码:1517 / 1534
页数:18
相关论文
共 241 条
[1]   Glyceryl trinitrate triggers premonitory symptoms in migraineurs [J].
Afridi, SK ;
Kaube, H ;
Goadsby, PJ .
PAIN, 2004, 110 (03) :675-680
[2]   Where do triptans act in the treatment of migraine? [J].
Ahn, AH ;
Basbaum, AI .
PAIN, 2005, 115 (1-2) :1-4
[3]   Voltage-dependent calcium channels are involved in neurogenic dural vasodilatation via a presynaptic transmitter release mechanism [J].
Akerman, S ;
Williamson, DJ ;
Goadsby, PJ .
BRITISH JOURNAL OF PHARMACOLOGY, 2003, 140 (03) :558-566
[4]   The effect of anti-migraine compounds on nitric oxide-induced dilation of dural meningeal vessels [J].
Akerman, S ;
Williamson, DJ ;
Kaube, H ;
Goadsby, PJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 452 (02) :223-228
[5]   Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels [J].
Akerman, S ;
Williamson, DJ ;
Kaube, H ;
Goadsby, PJ .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 137 (01) :62-68
[6]   The effect of adrenergic compounds on neurogenic dural vasodilatation [J].
Akerman, S ;
Williamson, DJ ;
Hill, RG ;
Goadsby, PJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 424 (01) :53-58
[7]   Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors [J].
Akerman, S ;
Kaube, H ;
Goadsby, PJ .
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 142 (08) :1354-1360
[8]   Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception [J].
Akerman, S ;
Kaube, H ;
Goadsby, PJ .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 309 (01) :56-63
[9]   LOCUS COERULEUS - NEUROBIOLOGY OF A CENTRAL NORADRENERGIC NUCLEUS [J].
AMARAL, DG ;
SINNAMON, HM .
PROGRESS IN NEUROBIOLOGY, 1977, 9 :147-196
[10]  
[Anonymous], RES CLIN STUDIES HEA